Chronic obstructive pulmonary disease (COPD) claims around three million lives worldwide every year and remains a major global respiratory health challenge. Although preventable and treatable, the disease is frequently underdiagnosed, meaning millions of people may be missing opportunities for earlier diagnosis and effective care.
Ahead of World COPD Day on Nov. 18, 2026, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a member, is emphasizing the importance of recognizing COPD earlier and improving access to treatment. This year's World COPD Day theme, led by the Global Initiative for Chronic Obstructive Lung Disease (GOLD), is "Early Diagnosis and Management for a Better Life."
COPD is a common, preventable, and treatable disease, but extensive under- and misdiagnosis leads to patients receiving treatment later in the disease course. The realization that environmental factors other than tobacco smoking can contribute to COPD, that it can start early in life and affect young individuals, and that there are precursor conditions (pre-COPD, PRISm), opens new windows of opportunity for its prevention, early diagnosis, and prompt and appropriate treatment.
There are many factors that can lead to delayed diagnosis of COPD, including patient-, health care system-, and provider-related factors. Patients may not recognize or report symptoms accurately, health care systems may not have resources to adequately train staff in respiratory health or to provide adequate access to spirometry within their communities, and providers may have a poor understanding of COPD diagnostic criteria.
It's important for health providers to look for the following factors that may place their adult patients at increased risk of COPD:
- Exposure to risk factors (tobacco smoke, household and outdoor air pollution, occupational exposures)
- Recurrent chest infections
- Genetic factors
- Prematurity and early life disadvantage factors
- Respiratory symptoms, including shortness of breath or chronic cough
Accurate and timely diagnosis of COPD can improve quality of life and health outcomes. Based on currently available evidence, GOLD advocates for active case finding, including performing spirometry in individuals with symptoms and/or risk factors.
In addition to earlier diagnosis, early treatment of COPD can slow disease progression, reduce symptom burden, and prevent future exacerbations. Intervention at an earlier stage, especially in symptomatic individuals or those with evidence of airflow limitation, can meaningfully improve long‑term outcomes. Prompt initiation of appropriate bronchodilator therapy, smoking cessation support, and risk‑factor reduction can help preserve lung function and enhance quality of life.
Although there is currently no cure for COPD, steps to help improve diagnosis and treatment can have a positive impact on future health:
- Patients and families can help advocate for more research and better access to care, including routine spirometry screenings and telehealth access for patients in remote settings.
- Providers and policy makers can work together to improve access to spirometry and advocate for its use as a general health marker in all stages of life.
- Health systems can work to increase academic training programs specializing in respiratory health, as well as improve training in COPD diagnostic criteria, including the use and interpretation of spirometry.
- Governments can implement measures to reduce smoking rates, decrease the use of fossil fuels to improve air quality, promote clean energy sources, encourage environmentally friendly practices, and improve access to quality health care for early diagnosis and treatment.
GOLD will continue to work with national leaders and other interested health care professionals to bring COPD to the attention of governments, public health officials, health care workers, and the public, to raise awareness of the burden of COPD and to develop programs for early detection, prevention and approaches to management.